
Chronic Obstructive Pulmonary Disease Market Expected To Experience Major Growth By 2034, According To Delveinsight ...
(MENAFN- GetNews) The Key Chronic Obstructive Pulmonary Disease Companies in the market include – Genentech, Inc., GlaxoSmithKline, Verona Pharma plc, Regeneron Pharmaceuticals, Sanofi, MedImmune LLC, EpiEndo Pharmaceuticals, Tetherex Pharmaceuticals, …